Is There an Optimal Timing for Surgical Ligation of Patent Ductus Arteriosus in Preterm Infants?

Annals of Thoracic Surgery

Volumn 87, Issue 5, 2009, Pages 1509-1516

  Vida, Vladimiro L ^a   Lago, Paola ^a   Salvatori, Sabrina ^a   Boccuzzo, Giovanna ^a   Padalino, Massimo A ^a   Milanesi, Ornella ^a   Speggiorin, Simone ^a   Stellin, Giovanni ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INOTROPIC AGENT; VASOACTIVE AGENT;

ABDOMINAL PENETRATING TRAUMA; ACUTE KIDNEY FAILURE; ARTICLE; BODY WEIGHT; BRAIN HEMORRHAGE; FEMALE; GESTATIONAL AGE; HUMAN; HYPOTENSION; INCIDENCE; INFANT; LIGATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETINOPATHY; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APGAR SCORE; BIRTH WEIGHT; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HOSPITAL MORTALITY; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 64649099174     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.12.101     Document Type: Article

References (34)

1. Knight D.B. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 6 (2001) 63-73
2. Palder SB, Schwartz MZ, Tyson KR, Marr CC. Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment. J Pediatr Surg 198;22:1171-4.
3. Ehrenkranz R.A., Walsh M.C., Vohr B.R., et al., National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116 (2005) 1353-1360
4. Little D.C., Pratt T.C., Blalock S.E., Krauss D.R., Cooney D.R., and Custer M.D. Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 38 (2003) 492-496
5. Clements K.M., Barfield W.D., Ayadi M.F., and Wilber N. Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics 119 (2007) e866-e874
6. Malviya M., Ohlsson A., and Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2003) :CD003951.
7. Russell J.L., Leblanc J.G., Potts J.E., and Sett S.S. Is surgical closure of patent ductus arteriosus a safe procedure in premature infants?. Int Surg 83 (1998) 358-360
8. Donze A., Smith J.R., and Bryowsky K. Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence. Neonatal Netw 26 (2007) 187-195
9. Giniger R.P., Buffat C., Millet V., and Simeoni U. Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants. J Matern Fetal Neonatal Med 20 (2007) 275-283
10. Lago P., Bettiol T., Salvadori S., et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161 (2002) 202-207
11. Sekar K.C., and Corff K.E. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?. J Perinatol 28 Suppl 1 (2008) S60-S62
12. Rajadurai V.S., and Yu V.Y. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus. J Paediatr Child Health 27 (1991) 370-375
13. Brooks J.M., Travadi J.N., Patole S.K., Doherty D.A., and Simmer K. Is surgical ligation of patent ductus arteriosus necessary?. The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 90 (2005) F235-F239
14. Vicente W.V., Rodrigues A.J., Ribeiro P.J., et al. Dorsal minithoracotomy for ductus arteriosus clip closure in premature neonates. Ann Thorac Surg 77 (2004) 1105-1106
15. Lippmann M., Nelson R.J., Emmanouilides G.C., Diskin J., and Thibeault D.W. Ligation of patent ductus arteriosus in premature infants. Br J Anaesth 48 (1976) 365-369
16. Lee L.C., Tillett A., Tulloh R., Yates R., and Kelsall W. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr 11 (2006) 6-15
17. Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., and Fanaroff A. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 150 (2007) 229-234
18. Van Overmeire B., Smets K., Lecoutere D., et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343 (2000) 674-681
19. Lago P., Ancora G., Bellieni C.V., et al. Gruppo di Studio II Dolore nel Neonato della Società Italiana di Neonatologia. Italian guidelines and recommendations for prevention and treatment of pain in the newborn. Pediatr Med Chir 28 (2006) 24-34
20. Zubrow A.B., Hulman S., Kushner H., and Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol 15 (1995) 470-479
21. O'Donovan D.J., Baetiong A., Adams K., et al. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus. J Perinatol 23 (2003) 286-290
22. Bell M.J., Ternberg J.L., Feigin R.D., et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 187 (1978) 1-7
23. van den Anker J.N., de Groot R., Broerse H.M., et al. Assessment of glomerular filtration rate in preterm infants by serum creatinine: comparison with insulin clearance. Pediatrics 96 (1995) 1156-1158
24. Choker G., and Gouyon J.B. Diagnosis of acute renal failure in very preterm infants. Biol Neonate 86 (2004) 212-216
25. Jim W.T., Chiu N.C., Chen M.R., et al. Cerebral hemodynamic change and intraventricular hemorrhage in very low birth weight infants with patent ductus arteriosus. Ultrasound Med Biol 31 (2005) 197-202
26. Good W.V., Hardy R.J., Dobson V., et al. Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116 (2005) 15-23
27. Kruskal W.H., and Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Statist Assoc 47 (1952) 583-621
28. Freeman G.H., and Halton J.H. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38 (1951) 141-149
29. Cherif A., Jabnoun S., and Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol 24 (2007) 339-345
30. Niinikoski H., Alanen M., Parvinen T., Aantaa R., Ekblad H., and Kero P. Surgical closure of patent ductus arteriosus in very-low-birth-weight infants. Pediatr Surg Int 17 (2001) 338-341
31. Chorne N., Leonard C., Piecuch R., and Clyman R.I. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelpmental morbidity. Pediatrics 119 (2007) 1165-1174
32. Shenassa H., Sankaran K., Duncan W., Tyrrell M., and Bharadwaj B. Surgical ligation of patent ductus arteriosus in a neonatal intensive care setting is safe and cost effective. Can J Cardiol 2 (1986) 353-355
33. Russell R.B., Green N.S., Steiner C.A., et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 120 (2007) e1-e9
34. Gould D.S., Montenegro L.M., Gaynor J.W., et al. A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. Pediatrics 112 (2003) 1298-1301